Unit No:  [**Numeric Identifier 28674**] Admission Date: [**2183-4-13**] Discharge Date: [**2183-4-21**] Date of Birth:  [**2113-3-23**] Sex: Service:   DATE OF DECEASED:  [**2183-4-21**]  HISTORY OF PRESENT ILLNESS:  The patient is a 70-year-old male with a history of metastatic renal cell carcinoma, status post right nephrectomy in [**2157**] with known lung metastases status post left lower lobe and right lower lobe resection, right bronchial stent, XRT therapy, and phototherapy on [**10/2182**] and [**12/2182**], history of CAD status post MI in [**2174**] and [**2178**] with LAD stent, history of congestive heart failure with ejection fraction of 25 percent, diabetes mellitus with chronic renal insufficiency, presented with increasing shortness of breath at outside hospital, found to have whiteout of right lung and obstructive right mainstem bronchial stent.
On [**2183-4-15**], the patient underwent stent removal after the stent was noted to have migrated distally, with some granulation tissue present.
He was given Ativan and Dilantin.
Had a recurrent generalized tonic- clonic seizure in the afternoon and was loaded with fosphenytoin again.
Sodium 146, potassium 4.0, chloride 104, bicarbonate 32, BUN 69, creatinine 2.1, glucose 131, magnesium 2.1, and Dilantin 21.
EKG 106 beats per minute, normal sinus rhythm, normal axis and intervals, left atrial enlargement, old inferior myocardial infarction, and T-wave inversions in 1 and aVL.
The patient with metastatic renal cell carcinoma to the lung, status post right mainstem bronchial stent, status post removal with post-obstruction pneumonia.
Cultured for Streptococcus pneumoniae and MRSA on vancomycin and ceftriaxone.
He was given gentamicin and IV fluids 75 cc an hour.
History of aspirin allergy.
He was continued on Lipitor and his ACE inhibitor was held as the patient with single kidney.
He was continued on Epogen and was given gentle IV fluids as his urine output was low.
After discussion with the family on patient's poor prognosis, his treatment was converted to all palliative treatment, and Palliative Care consult was obtained.
Multiple embolic bilateral CVAs, source may be cardiogenic, although not a candidate for anticoagulation and history of aspirin allergy.
The patient was continued on Dilantin with a level of about 20.
DISPOSITION:  The patient's therapy was converted to palliative care and the patient's code status was converted to comfort measures only.
